Aromatase inhibitors combined with aspirin to prevent lung cancer in preclinical models.
Sign Up to like & getrecommendations! Published in 2018 at "Translational lung cancer research"
DOI: 10.21037/tlcr.2018.09.17
Abstract: Lung cancer is the leading cause of cancer mortality worldwide (1). Although the incidence rate of lung cancer in women is lower than that of breast cancer, the 5-year survival rate for lung cancer is… read more here.
Keywords: aromatase inhibitors; inhibitors combined; combined aspirin; lung cancer ... See more keywords
Multicenter, Single-Arm, Phase IV Study of Combined Aspirin and High-Dose “IVIG-SN” Therapy for Pediatric Patients with Kawasaki Disease
Sign Up to like & getrecommendations! Published in 2017 at "Korean Circulation Journal"
DOI: 10.4070/kcj.2016.0139
Abstract: Background and Objectives Intravenous immunoglobulin-SN (IVIG-SN) is a new human immunoglobulin product. Its safety is ensured by pathogen-elimination steps comprising solvent/detergent treatment and a nanofiltration process. This multicenter clinical study was designed to evaluate the… read more here.
Keywords: high dose; treatment; combined aspirin; study ... See more keywords